# Intralytix, Inc.

Intralytix, Inc. is a Columbia, MD biotechnology company and the first in the world to receive FDA and USDA approvals for bacteriophage-based food safety products. We develop, manufacture, and sell phage-based products for food safety, environmental sanitation, veterinary applications, human therapeutics, and probiotics. We also operate clinical trials for Crohn's disease (EcoActive), Shigella dysentery (ShigActive), vancomycin-resistant Enterococci (VRELysin), and Group B Strep (observational trial at the Eliava Institute).

## Products
- [FortiPhage™](https://www.intralytix.com/product/fortiphage) — Bacteriophage-based product, composed of three Myoviridae phages, to maintain healthy gut microflora
- [PhageBiotix™ GI](https://www.intralytix.com/product/phagebiotix-gi) — Advanced bacteriophage blend formulated for enhanced support of healthy gut microflora
- [CampyShield&trade;](https://www.intralytix.com/product/campyshield) — Targets <i>Campylobacter</i> spp., and <i>Campylobacter</i> jejuni in foods and food processing facilities (FDA)
- [Ecolicide&reg; PX](https://www.intralytix.com/product/ecolicide) — Targets <i>Escherichia coli </i>O157:H7 contamination on hides of live animals
- [EcoShield&trade; PX](https://www.intralytix.com/product/ecoshield) — Targets Shiga toxin producing <i>Escherichia coli</i> (STEC), including O157:H7 and all “big six” STEC serotypes (FDA, FSIS, Health Canada, Israel Ministry of Health)
- [ListPhage&trade;](https://www.intralytix.com/product/listphage) — Targets <i>Listeria monocytogenes</i> contamination in pet food
- [ListShield&trade;](https://www.intralytix.com/product/listshield) — Targets <i>Listeria monocytogenes</i> contamination in foods and food processing facilities (FDA, FSIS, Health Canada, Israel Ministry of Health)
- [SalmoFresh&trade;](https://www.intralytix.com/product/salmofresh) — Targets contamination with selected, highly pathogenic <i>Salmonella</i>-serotypes in foods and food processing facilities (FDA, FSIS, Health Canada, Israel Ministry of Health)
- [SalmoLyse&reg;](https://www.intralytix.com/product/salmolyse) — Targets <i>Salmonella</i> contamination in pet food (FDA CVM)
- [ShigaShield&trade;](https://www.intralytix.com/product/shigashield) — Targets contamination with <i>Shigella</i> spp. in foods and food processing facilities (FDA)
- [FortiPhage™ Plus](https://www.intralytix.com/product/fortiphage-plus) — Bacteriophage-based product plus probiotics
- [SuperBiotix™ UTS](https://www.intralytix.com/product/superbiotix-uts) — Bacteriophage-based dietary ingredient to help maintain healthy gut and urinary tract microflora

## Regulatory Approvals
- FDA: CampyShield, EcoShield, ListShield, SalmoFresh, ShigaShield
- FDA CVM: SalmoLyse
- FSIS: EcoShield, ListShield, SalmoFresh
- Health Canada: EcoShield, ListShield, SalmoFresh
- Israel Ministry of Health: EcoShield, ListShield, SalmoFresh

## Clinical Trials
- [EcoActive&trade;](https://www.intralytix.com/clinical-trial/1) — Targeting adherent-invasive <i>E. coli</i> (AIEC) in Crohn's disease (New York, NY)
- [VRELysin&trade;](https://www.intralytix.com/clinical-trial/3) — Targeting vancomycin-resistant <i>Enterococci</i> in the gut (Pittsburgh, PA)
- [ShigActive&trade;](https://www.intralytix.com/clinical-trial/4) — Targeting <i>Shigella</i>, the causative agent of dysentery (Baltimore, MD)
- [EcoActive&trade;](https://www.intralytix.com/clinical-trial/5) — Targeting adherent-invasive <i>E. coli</i> (AIEC) in Crohn's disease (Baltimore Metro Area, MD)

## Differentiators
- First company in the world to receive FDA and USDA approvals for phage-based food safety products
- Largest portfolio of FDA-approved phage food safety products (5 in the USA; 3 also approved in Israel and Canada)
- Proprietary PhageSelector™ and AI-based PhageEngine™ platforms
- 15 issued patents plus pending applications
- In-house cGMP manufacturing (21 CFR 117), 1,500L fermentation, commercial spray drying
- Kosher, Halal, organic-compliant; SQF-certified

## APIs for AI agents
- [Public catalog API](https://www.intralytix.com/api/public/catalog) — JSON, no auth, rate-limited
- [Company info](https://www.intralytix.com/api/public/company) — JSON
- [Machine-readable llms.txt as JSON](https://www.intralytix.com/api/public/llms.txt)

## Contact
- Website: https://www.intralytix.com
- Sales: sales@intralytix.com
- Info: info@intralytix.com
- Phone: +1 877 489-7424
- Address: 8681 Robert Fulton Drive, Columbia, MD 21046, United States of America

## Keywords
Intralytix, biotechnology, bacteriophage, antibiotic resistance, phage therapy, phage company, food safety, antimicrobial solutions, phage probiotics, bacterial infections, drug resistance

## More info
- [Full llms.txt](https://www.intralytix.com/llms-full.txt) — expanded product, trial, patent, publication, and FAQ details
- [Why Intralytix](https://www.intralytix.com/why-intralytix) — differentiators and capabilities
- [Products page](https://www.intralytix.com/products) — full product catalog
- [Publications](https://www.intralytix.com/publications) — peer-reviewed research
- [Patents](https://www.intralytix.com/patents) — issued patents and trademarks
- [Clinical Trials](https://www.intralytix.com/clinical-trials) — ongoing trials
- [FAQ](https://www.intralytix.com/faq) — frequently asked questions